214 related articles for article (PubMed ID: 25186098)
1. Immunophenotyping does not improve predictivity of the local lymph node assay in mice.
Strauss V; Kolle SN; Honarvar N; Dammann M; Groeters S; Faulhammer F; Landsiedel R; van Ravenzwaay B
J Appl Toxicol; 2015 Apr; 35(4):434-45. PubMed ID: 25186098
[TBL] [Abstract][Full Text] [Related]
2. Local lymph node assay: differentiating allergic and irritant responses using flow cytometry.
Gerberick GF; Cruse LW; Ryan CA
Methods; 1999 Sep; 19(1):48-55. PubMed ID: 10525437
[TBL] [Abstract][Full Text] [Related]
3. Intracellular expression of cytokines and granzyme B in auricular lymph nodes draining skin exposed to irritants and sensitizers.
Ku HO; Jeong SH; Kang HG; Pyo HM; Cho JH; Son SW; Kim HR; Lee KJ; Ryu DY
Toxicology; 2008 Sep; 250(2-3):116-23. PubMed ID: 18652873
[TBL] [Abstract][Full Text] [Related]
4. Comparison of BALB/c and CBA/J mice for the local lymph node assay using bromodeoxyuridine with flow cytometry (LLNA: BrdU-FCM).
Lee YS; Yi JS; Seo SJ; Kim JH; Jung MS; Seo IK; Ahn I; Ko K; Kim TS; Lim KM; Sohn S
Regul Toxicol Pharmacol; 2017 Feb; 83():13-22. PubMed ID: 27816673
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiles in auricle skin as a possible additional endpoint for determination of sensitizers: A multi-endpoint evaluation of the local lymph node assay.
Tsuchiyama H; Maeda A; Nakajima M; Kitsukawa M; Takahashi K; Miyoshi T; Mutsuga M; Asaoka Y; Miyamoto Y; Oshida K
Toxicol Lett; 2017 Oct; 280():133-141. PubMed ID: 28826779
[TBL] [Abstract][Full Text] [Related]
6. Application of BALB/c mouse in the local lymph node assay:BrdU-ELISA for the prediction of the skin sensitizing potential of chemicals.
Hou F; Xing C; Li B; Cheng J; Chen W; Zhang M
J Pharmacol Toxicol Methods; 2015; 72():53-8. PubMed ID: 25600862
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the dermal sensitizing potential of traditional medical extracts in local lymph node assays.
Lv L; Yan GY; Zhao YL; He XJ; Jiang X; Zhuo YQ; Wang YL; Wang L; Cen XB
Exp Biol Med (Maywood); 2009 Mar; 234(3):306-13. PubMed ID: 19144870
[TBL] [Abstract][Full Text] [Related]
8. Utilization of the ex vivo LLNA: BrdU-ELISA to distinguish the sensitizers from irritants in respect of 3 end points-lymphocyte proliferation, ear swelling, and cytokine profiles.
Arancioglu S; Ulker OC; Karakaya A
Int J Toxicol; 2015; 34(1):24-30. PubMed ID: 25563296
[TBL] [Abstract][Full Text] [Related]
9. Use of a B cell marker (B220) to discriminate between allergens and irritants in the local lymph node assay.
Gerberick GF; Cruse LW; Ryan CA; Hulette BC; Chaney JG; Skinner RA; Dearman RJ; Kimber I
Toxicol Sci; 2002 Aug; 68(2):420-8. PubMed ID: 12151637
[TBL] [Abstract][Full Text] [Related]
10. Advantage of using CBA/N strain mice in a non-radioisotopic modification of the local lymph node assay.
Takeyoshi M; Noda S; Yamasaki K; Kimber I
J Appl Toxicol; 2006; 26(1):5-9. PubMed ID: 16217858
[TBL] [Abstract][Full Text] [Related]
11. Qualitative and quantitative evaluation of a local lymph node assay based on ex vivo interleukin-2 production.
Azam P; Peiffer JL; Ourlin JC; Bonnet PA; Tissier MH; Vian L; Fabre I
Toxicology; 2005 Jan; 206(2):285-98. PubMed ID: 15588920
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the performance of the reduced local lymph node assay for skin sensitization testing.
Ezendam J; Muller A; Hakkert BC; van Loveren H
Regul Toxicol Pharmacol; 2013 Jun; 66(1):66-71. PubMed ID: 23459101
[TBL] [Abstract][Full Text] [Related]
13. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.
Gerberick GF; Ryan CA; Dearman RJ; Kimber I
Methods; 2007 Jan; 41(1):54-60. PubMed ID: 16938465
[TBL] [Abstract][Full Text] [Related]
14. Analysis of differential gene expression in auricular lymph nodes draining skin exposed to sensitizers and irritants.
Ku HO; Jeong SH; Kang HG; Pyo HM; Cho JH; Son SW; Ryu DY
Toxicol Lett; 2008 Feb; 177(1):1-9. PubMed ID: 18242016
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of an ex vivo murine local lymph node assay: multiple endpoint comparison.
Piccotti JR; Knight SA; Gillhouse K; Lagattuta MS; Bleavins MR
J Appl Toxicol; 2006; 26(4):333-40. PubMed ID: 16705757
[TBL] [Abstract][Full Text] [Related]
16. Differential gene expression responses distinguish contact and respiratory sensitizers and nonsensitizing irritants in the local lymph node assay.
Adenuga D; Woolhiser MR; Gollapudi BB; Boverhof DR
Toxicol Sci; 2012 Apr; 126(2):413-25. PubMed ID: 22302311
[TBL] [Abstract][Full Text] [Related]
17. An in vitro human skin test for assessing sensitization potential.
Ahmed SS; Wang XN; Fielding M; Kerry A; Dickinson I; Munuswamy R; Kimber I; Dickinson AM
J Appl Toxicol; 2016 May; 36(5):669-84. PubMed ID: 26251951
[TBL] [Abstract][Full Text] [Related]
18. A nonradioisotopic endpoint for measurement of lymph node cell proliferation in a murine allergic contact dermatitis model, using bromodeoxyuridine immunohistochemistry.
Lee JK; Park JH; Park SH; Kim HS; Oh HY
J Pharmacol Toxicol Methods; 2002; 48(1):53-61. PubMed ID: 12750042
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of skin sensitization potential of chemicals by local lymph node assay using 5-bromo-2-deoxyuridine with flow cytometry.
Han BI; Yi JS; Seo SJ; Kim TS; Ahn I; Ko K; Kim JH; Bae S; Lee JK
Regul Toxicol Pharmacol; 2019 Oct; 107():104401. PubMed ID: 31158384
[TBL] [Abstract][Full Text] [Related]
20. B cell increases and ex vivo IL-2 production as secondary endpoints for the detection of sensitizers in non-radioisotopic local lymph node assay using flow cytometry.
Jung KM; Jang WH; Lee YK; Yum YN; Sohn S; Kim BH; Chung JH; Park YH; Lim KM
Toxicol Lett; 2012 Mar; 209(3):255-63. PubMed ID: 22245253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
